Citation
Nguyen, Thi Thuy Uyen, et al. "Effects of Probiotics, Prebiotics, and Synbiotics On Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: a Systematic Review and Meta-Analysis of Randomized Controlled Trials." Journal of Clinical Medicine, vol. 10, no. 19, 2021.
Nguyen TTU, Kim HW, Kim W. Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2021;10(19).
Nguyen, T. T. U., Kim, H. W., & Kim, W. (2021). Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine, 10(19). https://doi.org/10.3390/jcm10194456
Nguyen TTU, Kim HW, Kim W. Effects of Probiotics, Prebiotics, and Synbiotics On Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2021 Sep 28;10(19) PubMed PMID: 34640474.
TY - JOUR
T1 - Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
AU - Nguyen,Thi Thuy Uyen,
AU - Kim,Hyeong Wan,
AU - Kim,Won,
Y1 - 2021/09/28/
PY - 2021/08/15/received
PY - 2021/09/24/revised
PY - 2021/09/24/accepted
PY - 2021/10/13/entrez
PY - 2021/10/14/pubmed
PY - 2021/10/14/medline
KW - chronic kidney disease
KW - hemodialysis
KW - prebiotic
KW - probiotic
KW - synbiotic
JF - Journal of clinical medicine
JO - J Clin Med
VL - 10
IS - 19
N2 - The dysbiosis of gut microbiota may cause many complications in patients with end-stage renal disease, which may be alleviated by probiotic, prebiotic, and synbiotic supplementation. The aim of this systematic review and meta-analysis was to assess the effects of these supplementations on circulatory uremic toxins, biomarkers of inflammation, and oxidative stress in hemodialysis patients. We searched the EMBASE, MEDLINE, Web of Science, and Cochrane Library databases until 8 August 2021. Randomized controlled trials evaluating adult patients receiving hemodialysis were included. The pooled results from 23 studies with 931 hemodialysis patients indicated that interventions significantly decreased the circulating levels of p-cresyl sulfate (standardized mean difference (SMD): 0.38; 95% CI: -0.61, -0.15; p = 0.001), endotoxins (SMD: -0.58; 95% CI: -0.99, -0.18; p = 0.005), malondialdehyde (SMD: -1.16; 95% CI: -1.81, -0.52; p = 0.0004), C-reactive proteins (CRP) (SMD: -0.61; 95% CI: -0.99, -0.23; p = 0.002), and interleukin 6 (SMD: -0.92; 95% CI: -1.51, -0.33; p = 0.002), and improved the total antioxidant capacity (SMD: 0.89; 95% CI: 0.49, 1.30; p < 0.0001) and glutathione (SMD: 0.40; 95% CI: 0.14, 0.66; p = 0.003) when compared to the placebo group. Our results suggest that treatment with probiotics, prebiotics, and synbiotics may help alleviate uremic toxin levels, oxidative stress, and the inflammatory status in hemodialysis patients.
SN - 2077-0383
UR - https://www.unboundmedicine.com/medline/citation/34640474/Effects_of_Probiotics_Prebiotics_and_Synbiotics_on_Uremic_Toxins_Inflammation_and_Oxidative_Stress_in_Hemodialysis_Patients:_A_Systematic_Review_and_Meta_Analysis_of_Randomized_Controlled_Trials_
DB - PRIME
DP - Unbound Medicine
ER -